GB0210464D0 - Therapeutic treatment - Google Patents

Therapeutic treatment

Info

Publication number
GB0210464D0
GB0210464D0 GBGB0210464.4A GB0210464A GB0210464D0 GB 0210464 D0 GB0210464 D0 GB 0210464D0 GB 0210464 A GB0210464 A GB 0210464A GB 0210464 D0 GB0210464 D0 GB 0210464D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic treatment
therapeutic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0210464.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB0210464.4A priority Critical patent/GB0210464D0/en
Publication of GB0210464D0 publication Critical patent/GB0210464D0/en
Priority to DK03727868.6T priority patent/DK1506233T3/da
Priority to EP03727868.6A priority patent/EP1506233B8/en
Priority to AU2003233116A priority patent/AU2003233116B2/en
Priority to US10/513,740 priority patent/US7270822B2/en
Priority to CA002485223A priority patent/CA2485223A1/en
Priority to PCT/IB2003/002366 priority patent/WO2003095490A1/en
Priority to JP2004503504A priority patent/JP2006500321A/ja
Priority to US11/892,499 priority patent/US7713533B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
GBGB0210464.4A 2002-05-08 2002-05-08 Therapeutic treatment Ceased GB0210464D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0210464.4A GB0210464D0 (en) 2002-05-08 2002-05-08 Therapeutic treatment
DK03727868.6T DK1506233T3 (da) 2002-05-08 2003-05-08 Aktivt kompleks af alpha-lactalbumin (hamlet)samt co-faktor
EP03727868.6A EP1506233B8 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor
AU2003233116A AU2003233116B2 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor
US10/513,740 US7270822B2 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor
CA002485223A CA2485223A1 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor
PCT/IB2003/002366 WO2003095490A1 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor
JP2004503504A JP2006500321A (ja) 2002-05-08 2003-05-08 α−ラクトアルブミン（ＨＡＭＬＥＴ）および補因子の活性複合体
US11/892,499 US7713533B2 (en) 2002-05-08 2007-08-23 Active complex of α-lactalbumin (HAMLET) and cofactor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0210464.4A GB0210464D0 (en) 2002-05-08 2002-05-08 Therapeutic treatment

Publications (1)

Publication Number Publication Date
GB0210464D0 true GB0210464D0 (en) 2002-06-12

Family

ID=9936230

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0210464.4A Ceased GB0210464D0 (en) 2002-05-08 2002-05-08 Therapeutic treatment

Country Status (8)

Country Link
US (2) US7270822B2 (enExample)
EP (1) EP1506233B8 (enExample)
JP (1) JP2006500321A (enExample)
AU (1) AU2003233116B2 (enExample)
CA (1) CA2485223A1 (enExample)
DK (1) DK1506233T3 (enExample)
GB (1) GB0210464D0 (enExample)
WO (1) WO2003095490A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
WO2005082406A1 (en) * 2004-02-26 2005-09-09 Hamlet Pharma Ab Lactalbumin for inhibiting angiogenesis
GB0408752D0 (en) * 2004-04-20 2004-05-26 Hamlet Ltd Therapeutic treatment
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
WO2009135494A2 (en) * 2008-05-09 2009-11-12 Nya Hamlet Pharma Ab Alpha-lactalbumin composition for the treatment of actinic keratosis
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348376A (en) 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
JP2961625B2 (ja) 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法
US6455673B1 (en) 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
CA2197659C (en) 1994-08-16 2009-11-10 Hemant Sabharwal Antibacterial composition containing multimeric alpha-lactalbumin
US6159748A (en) 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5614191A (en) 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
ATE361319T1 (de) 1997-11-21 2007-05-15 Nya Hamlet Pharma Ab Herstellungsverfahren von lactalbumin
GB9725126D0 (en) 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
CA2396871A1 (en) 2000-01-20 2001-12-20 Ottawa Health Research Institute Immunostimulatory nucleic acids for inducing a th2 immune response
EP1268534A2 (en) 2000-03-24 2003-01-02 Filgen Biosciences, Inc. Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
AU2001266557A1 (en) * 2000-04-12 2001-10-23 Human Genome Sciences, Inc. Albumin fusion proteins
GB0205347D0 (en) 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
WO2005082406A1 (en) * 2004-02-26 2005-09-09 Hamlet Pharma Ab Lactalbumin for inhibiting angiogenesis

Also Published As

Publication number Publication date
AU2003233116A1 (en) 2003-11-11
EP1506233B1 (en) 2014-04-02
JP2006500321A (ja) 2006-01-05
AU2003233116B2 (en) 2009-03-26
DK1506233T3 (da) 2014-07-07
US20080167233A1 (en) 2008-07-10
US7713533B2 (en) 2010-05-11
EP1506233A1 (en) 2005-02-16
EP1506233B8 (en) 2014-09-24
US7270822B2 (en) 2007-09-18
CA2485223A1 (en) 2003-11-20
US20060074017A1 (en) 2006-04-06
WO2003095490A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
GB0316912D0 (en) Therapeutic treatment
GB0320806D0 (en) Therapeutic treatment
GB0201674D0 (en) Medical treatment
SI1545256T1 (sl) Naprava za terapevtsko zdravljenje
GB0223367D0 (en) Therapeutic treatment
GB0218879D0 (en) Medical treatment
GB0223854D0 (en) Therapeutic treatment
GB0219660D0 (en) Therapeutic use
GB0210464D0 (en) Therapeutic treatment
GB0329275D0 (en) Therapeutic treatment
GB0307863D0 (en) Therapeutic treatment
GB0313772D0 (en) Therapeutic treatment
GB0211297D0 (en) Pain treatment
AU2003231937A8 (en) Therapeutic methods
SI1553950T1 (sl) Terapevtsko zdravljenje
GB0207138D0 (en) Novel therapeutic treatment
GB0207139D0 (en) Novel therapeutic treatment
GB0318323D0 (en) Therapeutic treatment
GB0321650D0 (en) Therapeutic treatment
GB0318552D0 (en) Therapeutic treatment
GB0321233D0 (en) Therapeutic treatment
GB0321235D0 (en) Therapeutic treatment
GB0300881D0 (en) Therapeutic treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)